On this page
FSSAI files three cases against Nestlé India over infant nutrition products
Our read
Any partnership, acquisition or portfolio review involving infant nutrition should apply heightened regulatory diligence to claims substantiation, nutrient specifications and India-specific compliance systems.
Watch
Any revision or stricter enforcement guidance on infant milk substitute marketing, health claims or nutrient tolerances.
The report,
FSSAI filed three adjudication cases against Nestle India over promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1, plus non-conforming biotin levels in a follow-up formula. The products allegedly breach infant-food promotion and nutrition regulations.
- Adjudication cases against Nestlé India
- Three separate adjudication cases
Reported figures
From the report. Source details below
| Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, | 2020 |
|---|---|
| Section 3 of the Infant Milk Substitutes Act, | 1992 |
| Nestle India shares down nearly 2% to ₹1,345.45 at | 1310 hours |
Also in the report
- Three separate adjudication cases
What to watch next
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Monitor competitor claims and prepare for category-wide compliance changes that could alter promotional economics.
The counter-case
The case against this reading — not reported by the source.
The cases could expose Nestlé India to product relabelling, promotional restrictions, recalls or batch-level disruptions in a high-trust infant-nutrition category. Even before any final adjudication, allegations involving infant formula can amplify parent and pediatrician concern, invite broader scrutiny of marketing practices and testing controls, and give competitors an opening. Repeated compliance questions may also undermine the company’s premium positioning and increase legal, quality-assurance and distribution costs.
The source
Published
Confirmed by ET Small Business, NDTV Profit, The Hindu BusinessLine, Mint, Business Today, Financial Express, Outlook Business, IndianWeb2
First seen